Laboratorios Farmaceuticos Rovi S.A. operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Laboratorios Farmaceuticos Rovi S.A. with three other
pharmaceutical manufacturers in Europe:
sales of 94.06 million Euro [US$110.66 million]
of which 86%
was Commercialized Vaccines),
of the United Kingdom
(£171.67 million [US$226.48 million]
of which 100%
was Antibodies & Related Products), and
Eczacibasi Ilac Sanayi ve T.A.S.
based in Turkey
(1.41 billion Turkish Liras [US$385.30 million]
of which 74%
was Personal Care).
During the year ended December of 2016, sales at
Laboratorios Farmaceuticos Rovi S.A. were 265.17 million Euro (US$311.96 million).
increase of 7.8%
versus 2015, when the company's sales were 246.01 million Euro.
This was the fifth consecutive year of sales increases at Laboratorios Farmaceuticos Rovi S.A.
(and since 2011, sales have increased a total of 44%).
Sales of Marketing saw an increase
15.3% in 2016, from
201.92 million Euro to 232.79 million Euro.
Not all segments of Laboratorios Farmaceuticos Rovi S.A. experienced an increase in sales in 2016:
sales of Production fell 3.8% to 110.88 million Euro.